Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Discovery & Development Clinical Trials

Video: How Can Pharma Improve Clinical Trials?

Clinical trials are integral to the drug development process. Yet, they are still affected by long-standing challenges, including poor recruitment and retention, the use of paper-based systems, and siloes among participating stakeholders. Though many in the industry agree that something must be done to address these challenges, practical steps are necessary to see real and lasting change. 

The Medicine Maker brought together an expert panel to discuss the challenges affecting clinical and what can be done to make a difference. 

Watch our video to learn more about the trends and challenges affecting clinical trials, including the growing prevalence of digital and decentralized trials, COVID-19 induced supply chain issues, and the impact the war on Ukraine is having on trials.

Participants:
 

Georg Schulz, EVP of Clinical Services & Senior Director of Corporate Development at Tanner Pharma Group, a global provider of pharmaceutical solutions

Georg has more than 25 years of senior executive experience in the pharmaceutical industry. He has a proven track record in strategy design and execution, organizational development, supply chain management, international air and sea transport, and cold chain management for pharmaceutical products. 

Dave Hanaman, President, Co-founder, and Chief Commercial Officer at Curavit

Dave co-launched Curavit over two years ago. He has spent more than a decade as an intelligence officer in the US Navy and was co-founder and director for 22 years of C3i, a global healthcare technology company, until it was sold. 

Claire Marsden, VP, Digital and Decentralised Solutions at Medable

Claire has worked in the industry for over 25 years. She has worked across all phases of clinical development in companies including GSK, Pfizer, Novartis, Bayer Alnylam, and IQVIA.

Andrea Valente, Chef Executive Officer at ClinOne

With over 20 years of industry experience, Andrea joined ClinOne after serving as Chief Operating Officer at Medable. She has an extensive background in life sciences technology product development, delivery operations, customer loyalty, and merger and acquisition strategy.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Maryam Mahdi

Deputy Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register